Venture Capital

Larimar Therapeutics' nomlabofusp receives Breakthrough Therapy Designation, paving an accelerated path for a potential disease-modifying treatment.

New data on MCO-010 gene therapy identifies ideal patients for Retinitis Pigmentosa, a key step as the one-time injection advances toward FDA approval.

Blueprint Capital Advisors' new list of 'Active Icons' honors industry giants not just for wealth, but for their commitment to shaping a more inclusive future.

With $1.2M in new funding, Validfor is unleashing agentic AI to tackle pharma's billion-dollar compliance problem and slash validation times.

A new screen protector promises glasses-free 3D on your iPhone. Can MOPIC succeed where tech giants have repeatedly failed?

Avacta's pre|CISION therapy shows faster, more potent, and more selective tumor targeting than Enhertu in an AI-driven study, paving the way for 2026 trials.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

A new platform is treating residential property management like a tech problem, using centralization and automation to reshape a fragmented industry.

A new JBF report reveals how independent restaurants are battling costs, tech, and expectations with surprising optimism and strategic shifts.

A top legal award for David Wittmann reveals his crucial role in guiding Massachusetts' tech startups and his deep commitment to community service.

A former Regeneron exec who built a blockbuster drug joins a medtech startup, signaling a major push to disrupt the multi-billion dollar chemo-port market.

The parent company of Hometown Hero CBD is launching Black Sheep Kratom, betting on quality and transparency in a booming but unregulated wellness category.

The meal kit giant partners with the celebrity chef for an Italian-inspired menu, a strategic move to capture a larger slice of the competitive market.

Soar Autism Center launches a free, 40-hour RBT course focused on the play-based ESDM model, tackling workforce shortages and raising care standards.

The architect of Tesla's dry electrode acquisition is back, betting on AM Batteries' DBE 2.0 to revolutionize how batteries are made. Here's why.

A new public-private partnership in Sweden aims to revolutionize EV batteries with high-density, sustainable graphite-silicon anodes.

With a new financial architect at the helm, HydroGraph aims to turn its breakthrough graphene technology into global commercial success.

As Flex heads to a key investor conference, a look at its record financials and pivotal role in building the high-stakes infrastructure for the AI era.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.